Condition
Acetaminophen Toxicity
Total Trials
7
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed5
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06549062RecruitingPrimary
Pharmacokinetics and Pharmacodynamics of Intravenous Paracetamol in Morbidly Obese and Non- Obese Patients.
NCT01465542CompletedPrimary
Treatment of APAP Toxicity With IV and Oral NAC 2008-2011
NCT03451487Not ApplicableCompletedPrimary
A Randomized, Single-blind, Parallel Group and Multiple - Dose Design Study
NCT01005173UnknownPrimary
Acetaminophen Biomarkers
NCT02322879Phase 4CompletedPrimary
Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing
NCT01575847CompletedPrimary
Adduct Dipstick for Diagnosis of Acetaminophen Toxicity
NCT00725179CompletedPrimary
Treatment of Acetaminophen Toxicity With N-acetylcysteine
Showing all 7 trials